Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
XSTEM by Xintela for Osteoarthritis: Likelihood of Approval
XSTEM is under clinical development by Xintela and currently in Phase II for Osteoarthritis. According to GlobalData, Phase II drugs...